Evidence map›Paper›PMID 41197566›Full record

ArticleNeuroImage. Clinical2025

Modulating the sense of agency in functional neurological disorder using real-time fMRI neurofeedback: a proof-of-concept study.

Eliane Müller, Serafeim Loukas, Salome Häuselmann, Cristina Concetti, Dimitri Van De Ville, Nicolas Gninenko, Selma Aybek

Abstract read
In one paragraph

Article in NeuroImage. Clinical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eliane MüllerDepartment of Neurology, Faculty of Science and Medicine, University of Fribourg, Switzerland; Neuro-X Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland; Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, Switzerland; Graduate School of Cellular and Biomedical Sciences (GCB), University of Bern, Switzerland.
Serafeim LoukasNeuro-X Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland; Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, Switzerland; Department of Radiology and Medical Informatics, University of Geneva, Switzerland.
Salome HäuselmannDepartment of Neurology, Faculty of Science and Medicine, University of Fribourg, Switzerland; Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, Switzerland; Graduate School of Cellular and Biomedical Sciences (GCB), University of Bern, Switzerland.
Cristina ConcettiDepartment of Neurology, Faculty of Science and Medicine, University of Fribourg, Switzerland.
Dimitri Van De VilleNeuro-X Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland; Department of Radiology and Medical Informatics, University of Geneva, Switzerland.
Nicolas GninenkoDepartment of Neurology, Faculty of Science and Medicine, University of Fribourg, Switzerland; Neuro-X Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland; Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, Switzerland; Department of Radiology and Medical Informatics, University of Geneva, Switzerland. Electronic address: nicolas.gninenko@unifr.ch.
Selma AybekDepartment of Neurology, Faculty of Science and Medicine, University of Fribourg, Switzerland. Electronic address: selma.aybek@unifr.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisrupted sense of agency (SoA), the perceived loss of control over one's actions, is common in functional neurological disorder (FND) and linked to abnormal activation in agency-related networks, particularly the right temporoparietal junction (rTPJ). This proof-of-concept study tested whether fMRI neurofeedback (NF) could enhance SoA in FND by targeting the rTPJ.

methodsIn this single-arm feasibility study, 18 patients with mixed FND symptoms completed three NF trainings during an adaptive visuomotor task, receiving intermittent visual feedback of their rTPJ activity. Pre- and post-training assessments included subjective agency ratings, neuroimaging during a transfer task, and clinical evaluations.

resultsGroup-level subjective agency significantly increased after training (p = 0.0083), driven by responders (n = 8) who exhibited rTPJ (p = 0.042) and supplementary motor area (SMA) upregulation (p = 0.015) in the first session, alongside consistent task engagement. Behavioral gains coincided with trend-level decreases in rTPJ-dorsolateral prefrontal cortex (dlPFC) connectivity (p = 0.098), while non-responders showed reduced rTPJ-SMA connectivity (p = 0.008). No group-level clinical improvements were observed, but higher initial rTPJ (p = 0.03, ρ = -0.78) and dlPFC (p = 0.03, ρ = -0.75) activation were negatively associated with changes in self-reported core symptoms.

conclusionNF from rTPJ activity is feasible in FND and may enhance explicit SoA in a subset of patients through early neural modulation and sustained engagement. High inter-individual variability underscores the need for sham-controlled trials with optimized, engaging feedback designs and longitudinal monitoring to identify patients who could benefit from NF.

Indexed as

Magnetic Resonance ImagingNervous System DiseasesNeurofeedbackPsychomotor PerformanceAdultFeasibility StudiesFemaleHumansMaleMiddle AgedProof of Concept StudySense of AgencyYoung AdultFunctional MRIFunctional neurological disorderNeurofeedbackSense of agencyTemporoparietal junction

Identifiers

PMID41197566
PMCPMC12637265

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.